These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29380144)

  • 1. Contemporary Perspectives in Durable Mechanical Circulatory Support: What Did We Learn in the Last 3 Years?
    Raikhelkar J; Uriel N
    Curr Cardiol Rep; 2018 Jan; 20(1):6. PubMed ID: 29380144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A contemporary review of mechanical circulatory support.
    Patel CB; Cowger JA; Zuckermann A
    J Heart Lung Transplant; 2014 Jul; 33(7):667-74. PubMed ID: 24721183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanical circulatory support devices in advanced heart failure: 2020 and beyond.
    Vieira JL; Ventura HO; Mehra MR
    Prog Cardiovasc Dis; 2020; 63(5):630-639. PubMed ID: 32971112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destination therapy: does progress depend on left ventricular assist device development?
    von Bayern MP; Cadeiras M; Deng MC
    Heart Fail Clin; 2007 Jul; 3(3):349-67. PubMed ID: 17723941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durable mechanical circulatory support devices.
    Patel CB; Rogers JG
    Prog Cardiovasc Dis; 2011; 54(2):132-43. PubMed ID: 21875512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support.
    Hanff TC; Birati EY
    Curr Heart Fail Rep; 2019 Oct; 16(5):168-179. PubMed ID: 31631240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of long-term mechanical circulatory support in patients with advanced heart failure.
    Stokes MB; Bergin P; McGiffin D
    Intern Med J; 2016 May; 46(5):530-40. PubMed ID: 26010730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of the implantable LVAD.
    Kadakia S; Moore R; Ambur V; Toyoda Y
    Gen Thorac Cardiovasc Surg; 2016 Sep; 64(9):501-8. PubMed ID: 27270581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Left Ventricular Assist Devices and Mechanical Circulatory Support.
    Desai SR; Hwang NC
    J Cardiothorac Vasc Anesth; 2018 Jun; 32(3):1193-1213. PubMed ID: 29519601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving trends in mechanical circulatory support: Clinical development of a fully magnetically levitated durable ventricular assist device.
    Sidhu K; Lam PH; Mehra MR
    Trends Cardiovasc Med; 2020 May; 30(4):223-229. PubMed ID: 31201005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
    Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destination therapy with left ventricular assist devices: for whom and when?
    Porepa LF; Starling RC
    Can J Cardiol; 2014 Mar; 30(3):296-303. PubMed ID: 24565254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery from heart failure with circulatory assist: a working group of the National, Heart, Lung, and Blood Institute.
    Reinlib L; Abraham W;
    J Card Fail; 2003 Dec; 9(6):459-63. PubMed ID: 14966786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse events in contemporary continuous-flow left ventricular assist devices: A multi-institutional comparison shows significant differences.
    Stulak JM; Davis ME; Haglund N; Dunlay S; Cowger J; Shah P; Pagani FD; Aaronson KD; Maltais S
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):177-89. PubMed ID: 26545967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.
    Heatley G; Sood P; Goldstein D; Uriel N; Cleveland J; Middlebrook D; Mehra MR;
    J Heart Lung Transplant; 2016 Apr; 35(4):528-36. PubMed ID: 27044532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Destination therapy with left ventricular assist devices: patient selection and outcomes.
    Slaughter MS; Meyer AL; Birks EJ
    Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-Year Clinical Outcome in End-Stage Heart Failure: Comparison of "High Urgent" Listing for Heart Transplantation with Mechanical Circulatory Support Implantation.
    Sunavsky J; Zittermann A; Oezpeker C; Fujita B; Fuchs U; Gummert JF; Schulz U
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):647-52. PubMed ID: 26177226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular device as destination therapy: are we there yet?
    Badiwala MV; Rao V
    Curr Opin Cardiol; 2009 Mar; 24(2):184-9. PubMed ID: 19532106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.